FORMULATIONS AND DOSING REGIMEN FOR PPAR-ALPHA MODULATORS

FORMULATIONS AND DOSING REGIMEN FOR PPAR-ALPHA MODULATORS

The present invention provides dosing regimens for PPAR-alpha agonist and compositions thereof. A further embodiment of the present invention is a solid oral formulation of Propanoic Acid, 2-[4-[3-[2,5-dihy-dro-1-[(4-methylphenyl)methyl]-5-oxo-1H-1,2,4-triazol-3-yl]propyl]phenoxyl-2-methyl- comprisi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MICHAEL, LAURA FREY, DERBY, MICHAEL ARTHUR, HARRIS, CYNTHIA JOYCE, HOWEY, DANIEL CHARLES, ABU-RADDAD, EYAS JAMAL
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MICHAEL, LAURA FREY
DERBY, MICHAEL ARTHUR
HARRIS, CYNTHIA JOYCE
HOWEY, DANIEL CHARLES
ABU-RADDAD, EYAS JAMAL
description The present invention provides dosing regimens for PPAR-alpha agonist and compositions thereof. A further embodiment of the present invention is a solid oral formulation of Propanoic Acid, 2-[4-[3-[2,5-dihy-dro-1-[(4-methylphenyl)methyl]-5-oxo-1H-1,2,4-triazol-3-yl]propyl]phenoxyl-2-methyl- comprising 75 mug or less of Propanoic Acid, 2-[4-[3-[2,5-dihydro-1-[(4-methylphenyl)methyl]-5-oxo-1H-1,2,4-triazol-3-yl]propyl]phenoxy]-2-methyl- per dosage unit.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2595770A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2595770A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2595770A13</originalsourceid><addsrcrecordid>eNrjZLB08w_yDfVxDPH09wtWcPRzUXDxD_b0c1cIcnX39HX1UwDKKwQEOAbpOvoEeDgq-Pq7gFT7BwXzMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JJ4Z0cjU0tTc3MDR0NjIpQAAElMKGQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FORMULATIONS AND DOSING REGIMEN FOR PPAR-ALPHA MODULATORS</title><source>esp@cenet</source><creator>MICHAEL, LAURA FREY ; DERBY, MICHAEL ARTHUR ; HARRIS, CYNTHIA JOYCE ; HOWEY, DANIEL CHARLES ; ABU-RADDAD, EYAS JAMAL</creator><creatorcontrib>MICHAEL, LAURA FREY ; DERBY, MICHAEL ARTHUR ; HARRIS, CYNTHIA JOYCE ; HOWEY, DANIEL CHARLES ; ABU-RADDAD, EYAS JAMAL</creatorcontrib><description>The present invention provides dosing regimens for PPAR-alpha agonist and compositions thereof. A further embodiment of the present invention is a solid oral formulation of Propanoic Acid, 2-[4-[3-[2,5-dihy-dro-1-[(4-methylphenyl)methyl]-5-oxo-1H-1,2,4-triazol-3-yl]propyl]phenoxyl-2-methyl- comprising 75 mug or less of Propanoic Acid, 2-[4-[3-[2,5-dihydro-1-[(4-methylphenyl)methyl]-5-oxo-1H-1,2,4-triazol-3-yl]propyl]phenoxy]-2-methyl- per dosage unit.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060810&amp;DB=EPODOC&amp;CC=CA&amp;NR=2595770A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060810&amp;DB=EPODOC&amp;CC=CA&amp;NR=2595770A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MICHAEL, LAURA FREY</creatorcontrib><creatorcontrib>DERBY, MICHAEL ARTHUR</creatorcontrib><creatorcontrib>HARRIS, CYNTHIA JOYCE</creatorcontrib><creatorcontrib>HOWEY, DANIEL CHARLES</creatorcontrib><creatorcontrib>ABU-RADDAD, EYAS JAMAL</creatorcontrib><title>FORMULATIONS AND DOSING REGIMEN FOR PPAR-ALPHA MODULATORS</title><description>The present invention provides dosing regimens for PPAR-alpha agonist and compositions thereof. A further embodiment of the present invention is a solid oral formulation of Propanoic Acid, 2-[4-[3-[2,5-dihy-dro-1-[(4-methylphenyl)methyl]-5-oxo-1H-1,2,4-triazol-3-yl]propyl]phenoxyl-2-methyl- comprising 75 mug or less of Propanoic Acid, 2-[4-[3-[2,5-dihydro-1-[(4-methylphenyl)methyl]-5-oxo-1H-1,2,4-triazol-3-yl]propyl]phenoxy]-2-methyl- per dosage unit.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB08w_yDfVxDPH09wtWcPRzUXDxD_b0c1cIcnX39HX1UwDKKwQEOAbpOvoEeDgq-Pq7gFT7BwXzMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JJ4Z0cjU0tTc3MDR0NjIpQAAElMKGQ</recordid><startdate>20060810</startdate><enddate>20060810</enddate><creator>MICHAEL, LAURA FREY</creator><creator>DERBY, MICHAEL ARTHUR</creator><creator>HARRIS, CYNTHIA JOYCE</creator><creator>HOWEY, DANIEL CHARLES</creator><creator>ABU-RADDAD, EYAS JAMAL</creator><scope>EVB</scope></search><sort><creationdate>20060810</creationdate><title>FORMULATIONS AND DOSING REGIMEN FOR PPAR-ALPHA MODULATORS</title><author>MICHAEL, LAURA FREY ; DERBY, MICHAEL ARTHUR ; HARRIS, CYNTHIA JOYCE ; HOWEY, DANIEL CHARLES ; ABU-RADDAD, EYAS JAMAL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2595770A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2006</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MICHAEL, LAURA FREY</creatorcontrib><creatorcontrib>DERBY, MICHAEL ARTHUR</creatorcontrib><creatorcontrib>HARRIS, CYNTHIA JOYCE</creatorcontrib><creatorcontrib>HOWEY, DANIEL CHARLES</creatorcontrib><creatorcontrib>ABU-RADDAD, EYAS JAMAL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MICHAEL, LAURA FREY</au><au>DERBY, MICHAEL ARTHUR</au><au>HARRIS, CYNTHIA JOYCE</au><au>HOWEY, DANIEL CHARLES</au><au>ABU-RADDAD, EYAS JAMAL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FORMULATIONS AND DOSING REGIMEN FOR PPAR-ALPHA MODULATORS</title><date>2006-08-10</date><risdate>2006</risdate><abstract>The present invention provides dosing regimens for PPAR-alpha agonist and compositions thereof. A further embodiment of the present invention is a solid oral formulation of Propanoic Acid, 2-[4-[3-[2,5-dihy-dro-1-[(4-methylphenyl)methyl]-5-oxo-1H-1,2,4-triazol-3-yl]propyl]phenoxyl-2-methyl- comprising 75 mug or less of Propanoic Acid, 2-[4-[3-[2,5-dihydro-1-[(4-methylphenyl)methyl]-5-oxo-1H-1,2,4-triazol-3-yl]propyl]phenoxy]-2-methyl- per dosage unit.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2595770A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title FORMULATIONS AND DOSING REGIMEN FOR PPAR-ALPHA MODULATORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T23%3A25%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MICHAEL,%20LAURA%20FREY&rft.date=2006-08-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2595770A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true